Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review

Janna de Boer; Erik Boot; Lissa van Gils; Therese van Amelsvoort; Janneke Zinkstok

doi:10.1002/ajmg.a.61324

Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review

Janna de Boer^*, Erik Boot, Lissa van Gils, Therese van Amelsvoort, Janneke Zinkstok

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	2292-2306
Number of pages	15
Journal	American Journal of Medical Genetics Part A
Volume	179
Issue number	11
Early online date	13 Aug 2019
DOIs	https://doi.org/10.1002/ajmg.a.61324
Publication status	Published - Nov 2019

Keywords

22q11
2 deletion syndrome
adverse effects
antipsychotic medication
systematic review
CARDIO-FACIAL SYNDROME
TREATMENT-RESISTANT PSYCHOSIS
ONSET PARKINSON DISEASE
RISK-FACTORS
SCHIZOPHRENIA
CLOZAPINE
ADULTS
NEUTROPENIA
ADOLESCENT
CHILDHOOD

Access to Document

10.1002/ajmg.a.61324Licence: CC BY-NC-ND

Cite this

de Boer, J., Boot, E., van Gils, L., van Amelsvoort, T., & Zinkstok, J. (2019). Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review. American Journal of Medical Genetics Part A, 179(11), 2292-2306. https://doi.org/10.1002/ajmg.a.61324

@article{a83539c1ae69403a80ba7f78b47299d8,

title = "Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review",

keywords = "22q11, 2 deletion syndrome, adverse effects, antipsychotic medication, systematic review, CARDIO-FACIAL SYNDROME, TREATMENT-RESISTANT PSYCHOSIS, ONSET PARKINSON DISEASE, RISK-FACTORS, SCHIZOPHRENIA, CLOZAPINE, ADULTS, NEUTROPENIA, ADOLESCENT, CHILDHOOD",

author = "{de Boer}, Janna and Erik Boot and {van Gils}, Lissa and {van Amelsvoort}, Therese and Janneke Zinkstok",

year = "2019",

month = nov,

doi = "10.1002/ajmg.a.61324",

language = "English",

volume = "179",

pages = "2292--2306",

journal = "American Journal of Medical Genetics Part A",

issn = "1552-4825",

publisher = "Wiley",

number = "11",

}

Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome : A systematic review. / de Boer, Janna; Boot, Erik; van Gils, Lissa; van Amelsvoort, Therese; Zinkstok, Janneke.

In: American Journal of Medical Genetics Part A, Vol. 179, No. 11, 11.2019, p. 2292-2306.

Research output: Contribution to journal › Review article › Academic › peer-review

TY - JOUR

T1 - Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome

T2 - A systematic review

AU - de Boer, Janna

AU - Boot, Erik

AU - van Gils, Lissa

AU - van Amelsvoort, Therese

AU - Zinkstok, Janneke

PY - 2019/11

Y1 - 2019/11

KW - 22q11

KW - 2 deletion syndrome

KW - adverse effects

KW - antipsychotic medication

KW - systematic review

KW - CARDIO-FACIAL SYNDROME

KW - TREATMENT-RESISTANT PSYCHOSIS

KW - ONSET PARKINSON DISEASE

KW - RISK-FACTORS

KW - SCHIZOPHRENIA

KW - CLOZAPINE

KW - ADULTS

KW - NEUTROPENIA

KW - ADOLESCENT

KW - CHILDHOOD

U2 - 10.1002/ajmg.a.61324

DO - 10.1002/ajmg.a.61324

M3 - Review article

VL - 179

SP - 2292

EP - 2306

JO - American Journal of Medical Genetics Part A

JF - American Journal of Medical Genetics Part A

SN - 1552-4825

IS - 11

ER -